Practice of Epidemiology Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Interferon beta and long-term disability in multiple sclerosis.

  2013cited by this paper
• Comparison of Approaches to Weight Truncation for Marginal Structural Cox Models

  2013cited by this paper
• On computing standard errors for marginal structural Cox models

  2013cited by this paper
• Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.

  2013cited by this paper
• Treatment with interferon beta for multiple sclerosis.

  2012cited by this paper
• Simulating from marginal structural models with time‐dependent confounding

  2012cited by this paper
• Treatment With Interferon Beta for Multiple Sclerosis—Reply

  2012cited by this paper
• Evaluating the potential benefit of interferon treatment in multiple sclerosis.

  2012cited by this paper
• The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding

  2012cited by this paper
• A simulation study of finite‐sample properties of marginal structural Cox proportional hazards models

  2012cited by this paper
• Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.

  2012influential reference
• Lung Cancer Survival With Herbal Medicine and Vitamins in a Whole-Systems Approach

  2011cited by this paper
• Time scale and adjusted survival curves for marginal structural cox models.

  2010cited by this paper
• Accuracy of Conventional and Marginal Structural Cox Model Estimators: A Simulation Study

  2010influential reference
• Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial

  2010cited by this paper
• Relation between three classes of structural models for the effect of a time-varying exposure on survival

  2010cited by this paper
• Comparing Mortality in Renal Patients on Hemodialysis versus Peritoneal Dialysis Using a Marginal Structural Model

  2010cited by this paper
• A sequential Cox approach for estimating the causal effect of treatment in the presence of time‐dependent confounding applied to data from the Swiss HIV Cohort Study

  2010cited by this paper
• Impact of multiple sclerosis relapses on progression diminishes with time

  2009cited by this paper
• HOW EFFECTIVE ARE DISEASE-MODIFYING DRUGS IN DELAYING PROGRESSION IN RELAPSING-ONSET MS?

  2008cited by this paper
• Immortal time bias in the study of effectiveness of interferon‐β in multiple sclerosis

  2008cited by this paper
• Estimation and extrapolation of optimal treatment and testing strategies

  2008cited by this paper
• Interferon‐β treatment and the natural history of relapsing‐remitting multiple sclerosis

  2008cited by this paper
• Relapses in multiple sclerosis are age- and time-dependent

  2008cited by this paper
• Constructing inverse probability weights for marginal structural models.

  2008influential reference
• New natural history of interferon‐β–treated relapsing multiple sclerosis

  2007cited by this paper
• Disability progression in multiple sclerosis is slower than previously reported

  2006cited by this paper
• Estimating causal effects from epidemiological data

  2006cited by this paper
• USING CAUSAL DIAGRAMS TO UNDERSTAND COMMON PROBLEMS IN SOCIAL EPIDEMIOLOGY

  2006cited by this paper
• Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.

  2003cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2003cited by this paper
• Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

  2002cited by this paper
• Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments

  2001cited by this paper
• Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

  2000influential reference
• Marginal Structural Models versus Structural nested Models as Tools for Causal inference

  2000cited by this paper
• Marginal Structural Models and Causal Inference in Epidemiology

  2000cited by this paper
• Association, Causation, And Marginal Structural Models

  1999cited by this paper
• Estimation of the causal effect of a time-varying exposure on the marginal mean of a repeated binary outcome. Commentary. Authors' reply

  1999cited by this paper
• Causal diagrams for epidemiologic research.

  1999cited by this paper
• Evidence of interferon β-1a dose response in relapsing-remitting MS

  1999cited by this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cited by this paper
• Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

  1995cited by this paper
• Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

  1993cited by this paper
• Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

  1990cited by this paper
• Scales for rating impairment in multiple sclerosis

  1988cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• On the treatment of grouped observations in life studies.

  1977cited by this paper

• Effect of sodium bicarbonate infusion on hospital mortality in acute kidney injury patients with metabolic acidosis

  2023cites this paper
• Early sodium bicarbonate infusion was associated with improved outcome in critically ill patients with acute moderate metabolic acidosis: a retrospective observational study

  2023cites this paper
• Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy

  2023cites this paper
• Potential causal links between long-term ambient particulate matter exposure and cardiovascular mortality: New evidence from a large community-based cohort in South China.

  2023cites this paper
• Potential causal links between long-term ambient particulate matter exposure and cerebrovascular mortality: Insights from a large cohort in southern China.

  2023cites this paper
• Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

  2023cites this paper
• Clinical effectiveness of sodium bicarbonate therapy on mortality for septic patients with acute moderate lactic acidosis

  2023influential citation
• Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse

  2023cites this paper
• Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis

  2022cites this paper
• Effectiveness of sodium bicarbonate infusion on mortality for elderly septic patients with acute metabolic acidosis

  2022cites this paper
• Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy

  2022cites this paper
• Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

  2022cites this paper
• Adherence to a priori-Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models

  2022cites this paper
• Practice of Epidemiology Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis

  2021cites this paper
• Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load

  2021cites this paper
• Instrumental variable estimation of marginal structural Cox model for time-varying treatments

  2021cites this paper
• A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosis.

  2021cites this paper
• Stratified Restricted Mean Survival Time Model for Marginal Causal Effect in Observational Survival Data.

  2021cites this paper
• Assessing long-term effectiveness of MS treatment — a matter of debate

  2021cites this paper
• The Validity and Efficiency of Hypothesis Testing in Observational Studies with Time-Varying Exposures

  2021influential citation
• Transfusion‐related Epstein‐Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study)

  2020cites this paper
• Hazard of complex regional pain syndrome following human papillomavirus vaccination among adolescent girls in the United States: a case-cohort analysis of insurance claims data

  2020cites this paper
• All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study

  2020cites this paper
• The Use of Sodium Bicarbonate for Metabolic Acidosis in Patients With Acute Kidney Injury.

  2020cites this paper
• Estimating long-term pollution exposure effects through inverse probability weighting methods with Cox proportional hazards models

  2020cites this paper
• Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study

  2020cites this paper
• Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis.

  2020cites this paper
• Dealing with Treatment-confounder Feedback and Sparse Follow-up in Longitudinal studies - Application of a Marginal Structural Model in a Multiple Sclerosis Cohort.

  2020cites this paper
• The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review

  2020cites this paper
• Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.

  2020influential citation
• Association Between the Use of Sodium Bicarbonate and Mortality in Acute Kidney Injury Using Marginal Structural Cox Model.

  2019cites this paper
• Mediation analysis for estimating cardioprotection of longitudinal RAS inhibition beyond lowering blood pressure and albuminuria in type 1 diabetes.

  2019cites this paper
• Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years

  2019cites this paper
• Patients with High-Disease-Activity Relapsing-Remitting Multiple Sclerosis in Real-World Clinical Practice: A Population-Based Study in Sweden.

  2019cites this paper
• Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment

  2019cites this paper
• The Effect of Serious Offending on Health: A Marginal Structural Model

  2018cites this paper
• Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

  2018cites this paper
• Complete manuscript title: Can We Train Machine Learning Methods to Outperform the High-dimensional Propensity Score Algorithm?

  2018cites this paper
• Methods for time‐varying exposure related problems in pharmacoepidemiology: An overview

  2017cites this paper
• ‘Progressive MS – macro views’: The need for novel clinical trial paradigms to enable drug development for progressive MS

  2017cites this paper
• A flexible parametric approach for estimating continuous‐time inverse probability of treatment and censoring weights

  2016cites this paper
• Epigenetic regulation of neurodevelopmental genes in response to in utero exposure to phthalate plastic chemicals: How can we delineate causal effects?

  2016cites this paper
• Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.

  2016cites this paper
• Web-Appendix 1 WEB-APPENDIX for “ Comparison of Statistical Approaches Dealing with Immortal Time Bias in Drug Effectiveness Studies ”

  2016cites this paper
• Observational data: Understanding the real MS world

  2016cites this paper
• Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis

  2016cites this paper
• Practice of Epidemiology Comparison of Statistical Approaches for DealingWith Immortal TimeBias in Drug Effectiveness Studies

  2016cites this paper
• Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.

  2016cites this paper
• Multiple sclerosis drugs: how much bang for the buck?

  2015cites this paper
• Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator

  2015cites this paper